Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Arkema comments on FY 2014 and mid term financial guidance


Friday, 1 Aug 2014 01:00am EDT 

Arkema SA:Sees FY 2014 EBITDA close to 800 mln euros.Sees 8 bln euro sales and 16 pct EBITDA margin in FY 2017.Says it had initially set targets of 8 bln euro sales and 16 pct EBITDA margin for FY 2016. 

Company Quote

80.3
 --
1 May 2015